Cidara Therapeutics, Inc.·4

Oct 2, 5:30 PM ET

Sandison Taylor 4

4 · Cidara Therapeutics, Inc. · Filed Oct 2, 2024

Insider Transaction Report

Form 4
Period: 2024-09-30
Sandison Taylor
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-09-30+166,836166,836 total
    Exercise: $10.75Exp: 2034-09-29Common Stock (166,836 underlying)
Footnotes (1)
  • [F1]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of September 30, 2024.

Documents

1 file
  • 4
    wk-form4_1727904614.xmlPrimary

    FORM 4